Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
C3is Inc. stock logo
CISS
C3is
$3.21
-0.6%
$3.43
$2.85
$22.80
$2.28M1.6930,375 shs24,570 shs
Globavend Holdings Limited stock logo
GVH
Globavend
$5.14
-0.8%
$86.17
$4.87
$364.00
$390K3.76582,187 shs42,036 shs
SQZ Biotechnologies stock logo
SQZ
SQZ Biotechnologies
$0.03
$0.03
$0.25
$3.56
$826K2.34455,220 shsN/A
USD Partners LP stock logo
USDP
USD Partners
$0.01
-7.1%
$0.01
$0.00
$0.10
$220K0.8334,648 shs50,745 shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
C3is Inc. stock logo
CISS
C3is
+1.25%-6.89%-3.00%-13.87%-83.18%
Globavend Holdings Limited stock logo
GVH
Globavend
-0.19%-3.90%-66.23%-98.18%-95.02%
SQZ Biotechnologies stock logo
SQZ
SQZ Biotechnologies
0.00%0.00%0.00%0.00%-24.32%
USD Partners LP stock logo
USDP
USD Partners
-4.11%-1.41%-12.50%-38.60%-85.60%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
C3is Inc. stock logo
CISS
C3is
0.4787 of 5 stars
0.02.00.00.03.30.00.6
Globavend Holdings Limited stock logo
GVH
Globavend
1.1938 of 5 stars
2.02.00.00.02.50.00.6
SQZ Biotechnologies stock logo
SQZ
SQZ Biotechnologies
N/AN/AN/AN/AN/AN/AN/AN/A
USD Partners LP stock logo
USDP
USD Partners
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
C3is Inc. stock logo
CISS
C3is
0.00
N/AN/AN/A
Globavend Holdings Limited stock logo
GVH
Globavend
4.00
Strong Buy$80.001,456.42% Upside
SQZ Biotechnologies stock logo
SQZ
SQZ Biotechnologies
0.00
N/AN/AN/A
USD Partners LP stock logo
USDP
USD Partners
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest SQZ, CISS, GVH, and USDP Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/10/2025
Globavend Holdings Limited stock logo
GVH
Globavend
Litchfield Hills Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy$80.00
(Data available from 8/14/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
C3is Inc. stock logo
CISS
C3is
$42.30M0.05$321.00 per share0.01$2,912.57 per share0.00
Globavend Holdings Limited stock logo
GVH
Globavend
$16.54M0.02$18.36 per share0.28$69.25 per share0.07
SQZ Biotechnologies stock logo
SQZ
SQZ Biotechnologies
$18.16M0.05N/AN/A$1.94 per share0.01
USD Partners LP stock logo
USDP
USD Partners
$72.32M0.00$0.65 per share0.01N/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
C3is Inc. stock logo
CISS
C3is
-$2.75M-$51.85N/AN/A3.62%7.94%5.19%8/28/2025 (Estimated)
Globavend Holdings Limited stock logo
GVH
Globavend
$1.34MN/A0.00N/AN/AN/AN/AN/A
SQZ Biotechnologies stock logo
SQZ
SQZ Biotechnologies
-$79.46M-$2.61N/AN/AN/A-369.96%-119.83%-59.90%N/A
USD Partners LP stock logo
USDP
USD Partners
$17.77M-$1.55N/AN/A-94.39%N/A-28.33%N/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
C3is Inc. stock logo
CISS
C3is
N/AN/AN/AN/AN/A
Globavend Holdings Limited stock logo
GVH
Globavend
N/AN/AN/AN/AN/A
SQZ Biotechnologies stock logo
SQZ
SQZ Biotechnologies
N/AN/AN/AN/AN/A
USD Partners LP stock logo
USDP
USD Partners
$0.497,538.46%N/AN/A N/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
C3is Inc. stock logo
CISS
C3is
N/A
1.01
0.94
Globavend Holdings Limited stock logo
GVH
Globavend
N/AN/AN/A
SQZ Biotechnologies stock logo
SQZ
SQZ Biotechnologies
N/A
3.50
3.50
USD Partners LP stock logo
USDP
USD Partners
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
C3is Inc. stock logo
CISS
C3is
10.54%
Globavend Holdings Limited stock logo
GVH
Globavend
N/A
SQZ Biotechnologies stock logo
SQZ
SQZ Biotechnologies
38.51%
USD Partners LP stock logo
USDP
USD Partners
0.09%

Insider Ownership

CompanyInsider Ownership
C3is Inc. stock logo
CISS
C3is
N/A
Globavend Holdings Limited stock logo
GVH
Globavend
N/A
SQZ Biotechnologies stock logo
SQZ
SQZ Biotechnologies
16.00%
USD Partners LP stock logo
USDP
USD Partners
2.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
C3is Inc. stock logo
CISS
C3is
N/A710,000N/ANo Data
Globavend Holdings Limited stock logo
GVH
Globavend
770,000N/ANot Optionable
SQZ Biotechnologies stock logo
SQZ
SQZ Biotechnologies
1,62029.49 million24.77 millionNot Optionable
USD Partners LP stock logo
USDP
USD Partners
9033.77 million32.90 millionNo Data

Recent News About These Companies

USD Completes Final Asset Sale of Hardisty Terminal
USD Partners Announces Sale of Its Final Asset
USD Partners Expects to Sell Final Asset by Mid-April
USD/MXN Forward Rates
Molecular Partners Advances Radio-DARPin Programs with Strong Funding
USD 3 Month LIBOR
Weekly Blockchain Blog - October 2024 #3
Ripple Unveils RLUSD Stablecoin with Exchange Partners
USDP USD Partners LP Common Units

New MarketBeat Followers Over Time

Media Sentiment Over Time

C3is stock logo

C3is NASDAQ:CISS

$3.21 -0.02 (-0.62%)
Closing price 03:59 PM Eastern
Extended Trading
$3.13 -0.08 (-2.62%)
As of 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

C3is Inc. offers international seaborne transportation services. It provides its services to dry bulk charterers, including national and private industrial users, commodity producers and traders, oil producers, refineries, and commodities traders and producers. The company owns and operates a fleet of two drybulk carriers, which transport major bulks, such as iron ore, coal and grains, as well as minor bulks comprising bauxite, phosphate, and fertilizers, and one Aframax crude oil tanker that transports crude oil. C3is Inc. was founded in 2021 and is based in Athens, Greece.

Globavend stock logo

Globavend NASDAQ:GVH

$5.14 -0.04 (-0.77%)
Closing price 04:00 PM Eastern
Extended Trading
$5.10 -0.04 (-0.78%)
As of 07:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Globavend Holdings Limited, together with its subsidiaries, provides integrated cross-border logistics services and air freight forwarding services in Hong Kong, Australia, and New Zealand. The company's services include parcel consolidation, air freight forwarding, customs clearance, on-carriage parcel transportation, and delivery. It serves e-commerce merchants and operators of e-commerce platforms. The company was founded in 2016 and is based in Perth, Australia. Globavend Holdings Limited is subsidiary of Globavend Investments Limited.

SQZ Biotechnologies stock logo

SQZ Biotechnologies NYSE:SQZ

$0.03 0.00 (0.00%)
As of 08/13/2025

SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination with immuno-oncology agents for the treatment of HPV16+ advanced or metastatic solid tumors, including cervical, head-and-neck, anal, penile, vulvar, and vaginal cancer. The company also develops SQZ-AAC-HPV, which is in a Phase I clinical trial for the treatment of HPV16+ advanced or metastatic solid tumors in monotherapy and in combinations with immune-oncology agents. Its additional platforms in development are SQZ Activating Antigen Carriers; and SQZ Tolerizing Antigen Carriers. The Company was incorporated in 2013 and is headquartered in Watertown, Massachusetts.

USD Partners stock logo

USD Partners NYSE:USDP

$0.0065 0.00 (-7.14%)
As of 02:38 PM Eastern

USD Partners LP acquires, develops, and operates midstream infrastructure assets and logistics solutions for crude oil, biofuels, and other energy-related products in the United States and Canada. It operates through two segments, Terminalling Services and Fleet Services. The Terminalling Services segment owns and operates Hardisty terminal, an origination terminal for loading various grades of Canadian crude oil onto railcars for transportation to end markets; Stroud terminal, a crude oil destination terminal, which is used to facilitate rail-to-pipeline shipments of crude oil located in Stroud, Oklahoma; Casper terminal, a crude oil storage, blending, and railcar loading terminal located in Casper, Wyoming; and West Colton Terminal, an unit train-capable destination terminals that trans load approximately 13,000 barrels per day ethanol and renewable diesel received by rail from producers onto trucks. The Fleet Services segment provides leased railcars and fleet services related to the transportation of liquid hydrocarbons. It operates a fleet of 200 railcars. USD Partners GP LLC serves as the general partner of the company. The company was incorporated in 2014 and is headquartered in Houston, Texas.